List of insiders holdings for POINT Biopharma Global Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Therapeutics Acquisition Holdings LLC 10% Owner | 2020-07-07 21:58:06 | 2,785,000 0 | 2,785,000 | Form 3 |
| Hammond Matthew Chief Financial Officer | 2020-07-07 21:59:21 | 0 2,785,000 | 2,785,000 | Form 3 |
| Kolchinsky Peter Chief Executive Officer | 2021-06-30 16:31:24 | 0 1,098,318 | 1,098,318 | Form 4 |
| Martell Bridget A Director | 2023-06-14 18:15:29 | 80,503 0 | 80,503 | Form 4 |
| GOTTLIEB MICHAEL M. Chief Commercial Officer | 2021-07-08 16:34:08 | 48,000 0 | 48,000 | Form 4 |
| GRAY MICHAEL Director | 2020-07-07 21:52:21 | 30,000 0 | 30,000 | Form 3 |
| Grau Daniel Director | 2020-07-07 21:51:50 | 30,000 0 | 30,000 | Form 3 |
| GILMOUR MARGARET E. Director | 2021-07-08 16:37:03 | 25,000 0 | 25,000 | Form 4 |
| GOODMAN JONATHAN R. Director | 2023-12-27 17:41:13 | 0 0 | 0 | Form 4 |
| KELLY JUSTYNA Chief Operating Officer | 2023-12-27 17:40:48 | 0 0 | 0 | Form 4 |
| MCCANN JOE A. Chief Executive Officer | 2023-12-27 17:40:37 | 0 0 | 0 | Form 4 |
| JENSEN JESSICA D. EVP Clinical Development | 2023-12-27 17:39:53 | 0 0 | 0 | Form 4 |
| FLESHNER NEIL E. Chief Medical Officer | 2023-12-27 17:39:23 | 0 0 | 0 | Form 4 |
| HOGUE GERALD L. Director | 2023-12-27 17:37:48 | 0 0 | 0 | Form 4 |
| Malik Rajesh Director | 2023-12-27 17:37:35 | 0 0 | 0 | Form 4 |
| Lubner David Charles Director | 2023-12-27 17:37:18 | 0 0 | 0 | Form 4 |
| DEMERS WILLIAM L. Chief Financial Officer | 2023-12-27 17:36:35 | 0 0 | 0 | Form 4 |
| SILBER ALLAN C Executive Chairman | 2023-12-27 17:35:38 | 0 0 | 0 | Form 4 |
| MARGOLIN YAEL Director | 2023-12-27 17:35:28 | 0 0 | 0 | Form 4 |
| BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N Former 10% Owner | 2023-12-20 18:09:54 | 0 0 | 0 | Form 4 |
| RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Shah Rajeev M. Director | 2022-09-26 17:29:14 | 0 0 | 0 | Form 13D |